Working… Menu

The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02300233
Recruitment Status : Completed
First Posted : November 24, 2014
Last Update Posted : November 5, 2019
Akcea Therapeutics
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 27, 2016
Actual Study Completion Date : January 24, 2017
Certification/Extension First Submitted : May 7, 2018